{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:23:28Z","timestamp":1767705808507},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Tunisian and French Ministries of Higher Education and Scientific Research"},{"DOI":"10.13039\/501100001665","name":"L\u2019Agence Nationale de la Recherche","doi-asserted-by":"crossref","award":["ANR-08-GENO-002-01"],"award-info":[{"award-number":["ANR-08-GENO-002-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.atherosclerosis.2012.02.018","type":"journal-article","created":{"date-parts":[[2012,2,19]],"date-time":"2012-02-19T10:32:09Z","timestamp":1329647529000},"page":"158-166","source":"Crossref","is-referenced-by-count":22,"title":["Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients"],"prefix":"10.1016","volume":"222","author":[{"given":"Afef","family":"Slimani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awatef","family":"Jelassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Jguirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Najah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamia","family":"Rebhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Omezzine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faouzi","family":"Maatouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaldoun Ben","family":"Hamda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Kacem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Rab\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Abifadel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustapha","family":"Rouis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Naceur","family":"Slimane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Varret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0005","series-title":"The metabolic and molecular bases of inherited disease","first-page":"2863","article-title":"Familial hypercholesterolemia","author":"Goldstein","year":"2001"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0010","series-title":"The metabolic and molecular bases of inherited disease","first-page":"2717","article-title":"Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins","author":"Kane","year":"2001"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0020","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.cca.2010.02.008","article-title":"Moderate phenotypic expression of familial hypercholesterolemia in Tunisia","volume":"411","author":"Jelassi","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jpeds.2009.02.022","article-title":"The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia","volume":"155","author":"Guardamagna","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2003.12.037","article-title":"Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia","volume":"174","author":"Bertolini","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00041433-200204000-00008","article-title":"Phenotypic variability in familial hypercholesterolemia: an update","volume":"13","author":"Jansen","year":"2002","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2012.02.018_bib0040","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/humu.20882","article-title":"Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease","volume":"30","author":"Abifadel","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0045","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/humu.20316","article-title":"The c.43_44insCTG variation in PCSK9 is associated with low plasma LDL-cholesterol in a Caucasian population","volume":"27","author":"Yue","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0050","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jacc.2005.01.051","article-title":"A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis","volume":"45","author":"Chen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-511X-10-5","article-title":"The proprotein convertase subtilisin\/kexin type 9 gene E670G polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations","volume":"10","author":"Aung","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2006.12.035","article-title":"Genetic variants in PCSK9 in the Japanese population: Rare genetic variants in PCSK9 might collectively contribute to plasma LDL cholesterol levels in the general population","volume":"196","author":"Miyake","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0065","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/aje\/155.6.487","article-title":"Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review","volume":"155","author":"Eichner","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0070","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/S0021-9258(18)34954-8","article-title":"Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site","volume":"257","author":"Weisgraber","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0075","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0080","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2008.07.011","article-title":"Limited mutational heterogeneity in the LDLR gene in familial hypercholesterolemia in Tunisia","volume":"203","author":"Jelassi","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0085","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ng1746","article-title":"Automating sequence-based detection and genotyping of SNPs from diploid samples","volume":"38","author":"Stephens","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0090","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","article-title":"Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI","volume":"31","author":"Hixson","year":"1990","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0095","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1136\/jmg.39.11.e74","article-title":"CYS127S (FH-Kairouan) and D245N (FH-Tozeur) mutations in the LDL receptor gene in Tunisian families with familial hypercholesterolaemia","volume":"39","author":"Slimane","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1172\/JCI114212","article-title":"Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors","volume":"84","author":"Hobbs","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0105","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1034\/j.1399-0004.1999.550506.x","article-title":"An individual with a healthy phenotype in spite of a pathogenic LDL receptor mutation C240F","volume":"55","author":"Ekstr\u00f6m","year":"1999","journal-title":"Clin Genet"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2006.10.003","article-title":"Genetic defects causing familial hypercholesterolaemia: identification of deletions and duplications in the LDL-receptor gene and summary of all mutations found in patients attending the Hammersmith Hospital Lipid Clinic","volume":"194","author":"Tosi","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1086\/302704","article-title":"A cholesterol lowering gene maps to chromosome 13.q","volume":"66","author":"Knoblauch","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0120","doi-asserted-by":"crossref","first-page":"E682","DOI":"10.1002\/humu.21002","article-title":"The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene","volume":"30","author":"Abifadel","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0125","article-title":"Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolemia","author":"Pisciotta","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2350-7-66","article-title":"The E670G SNP in the PCSK9 gene is associated with polygenic hypercholesterolemia in men but not in women","volume":"7","author":"Evans","year":"2006","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.atherosclerosis.2009.06.023","article-title":"Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE alleles","volume":"208","author":"Norata","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0140","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/500615","article-title":"A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol","volume":"78","author":"Kotowski","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0145","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/CS20070150","article-title":"The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men","volume":"113","author":"Scartezini","year":"2007","journal-title":"Clin Sci (Lond)"},{"issue":"3\u20134","key":"10.1016\/j.atherosclerosis.2012.02.018_bib0150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cca.2009.11.008","article-title":"Loss-of-function mutation R46L in the PCSK9 gene has little impact on the levels of total serum cholesterol in familial hypercholesterolemia heterozygotes","volume":"411","author":"Str\u00f8m","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0155","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/01.ATV.0000204337.81286.1c","article-title":"Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy","volume":"26","author":"Berge","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0160","first-page":"163","article-title":"Statins and ezetimibe modulate plasma proprotein convertase subtilisin kexin-9 (PCSK9) levels","volume":"120","author":"Davignon","year":"2009","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0165","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/CIRCGENETICS.108.818062","article-title":"Comprehensive whole genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort","volume":"2","author":"Thompson","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0170","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2005.08.015","article-title":"Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia","volume":"186","author":"Pisciotta","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0175","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/jmg.2008.059980","article-title":"A PCSK9 variant and familial combined hyperlipidaemia","volume":"45","author":"Abifadel","year":"2008","journal-title":"J Med Genet"},{"key":"10.1016\/j.atherosclerosis.2012.02.018_bib0180","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/humu.21660","article-title":"Genetic variation in APOB PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl Levels","volume":"33","author":"Huijgen","year":"2012","journal-title":"Hum Mutat"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915012001323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915012001323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T23:07:29Z","timestamp":1640819249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915012001323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0021915012001323"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.02.018","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}